Connect with us

Technology

Implantica deepens market penetration in Italy with the addition of the ninth RefluxStop™ Center of Excellence and several lined up to start near-term

Published

on

VADUZ, Liechtenstein, Dec. 17, 2024 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces the first RefluxStop™ procedures were completed this month by Dr Günther Sitzmann, head of General Surgery Department at Ospedale di Brunico, part of Azienda Sanitaria dell’Alto Adige, Brunico, Italy.

Dr. Sitzmann at Ospedale di Brunico performed the procedure on two patients, and both have recovered well. He was supported by Prof. Dr. med. Moustafa Elshafei of Nordwest Hospital Frankfurt, Germany. Based on this success, two more cases are already planned for January 2025.

Dr. Sitzmann says, “It’s exciting to be at the start of a revolution in the surgical treatment of GERD with RefluxStop™ leading the way. With RefluxStop™, I can offer the benefits of a durable surgical treatment to many more chronic GERD patients looking for an innovative solution to minimize their side effects and significantly improve their quality of life. This is sure to have a significant positive impact on the lives of GERD patients in our Dolomite Mountain community.”

The demand for RefluxStop™ continues with Ospedale di Brunico the ninth leading anti-reflux hospital in Italy to offer the RefluxStop™ procedure. Several new centers are lined up to get started in the coming months. RefluxStop™ has been performed in over 1000 patients across Europe, as top foregut surgeons turn to this innovative technology to help their chronic GERD patients.

The inventor of RefluxStop™ and founder and CEO of Implantica, Dr. Peter Forsell, says, “We’re proud to partner with Dr. Sitzmann of the esteemed Ospedale di Brunico as he seeks the most advanced treatments to offer GERD patients.” Dr. Forsell goes on to say, “Estimates show around 11 million people in Italy suffer from GERD, costing hundreds of millions of Euros to the healthcare system along with immeasurable negative impact on the lives of patients. I believe RefluxStop™ has the potential to drive a significant change in the surgical treatment of GERD for these patients and for generations to come.”

The RefluxStop™ procedure addresses the root cause of GERD by restoring the natural anatomy and physiology of the body. The unique mechanism of action of RefluxStop™ allows the surgeon to restore the anti-reflux barrier without encircling the food passageway, thus making a surgical solution for GERD available to countless patients who may not have been candidates for traditional surgical GERD procedures.

For further information, please contact:
Nicole Pehrsson, Chief Corporate Affairs Officer
Telephone (CH): +41 (0)79 335 09 49
nicole.pehrsson@implantica.com

Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.

The company’s Certified Adviser is FNCA Sweden AB, info@fnca.se

The information was sent for publication, through the agency of the contact person set out above, on December 17, 2024, at 08:30 a.m. (CET).

About Implantica

Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica’s lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energizing platform designed to power remote-controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.

About RefluxStop™

RefluxStop™ is a new innovative treatment that has the potential to spur a paradigm shift in anti-reflux surgery. It’s unique mechanism of action differentiates it from standard of care and current surgical solutions. Longer established surgical options for GORD involve encircling the food passageway to support the lower oesophageal sphincter’s closing mechanism and are commonly associated with side effects such as swallowing difficulties, pain when swallowing and inability to belch and/or vomit.

In contrast, the RefluxStop™ device treats the cause of acid reflux without encircling and putting pressure on the food passageway. It restores and maintains the lower oesophageal sphincter in its original, natural position.

The RefluxStop™ mechanism of action is focused on reconstructing all three components of the anti-reflux barrier, that if compromised could possibly result in acid reflux. It restores and supports the natural anatomical physiology of the body allowing the body to itself solve the problem with acid reflux.

Newsroom
https://www.implantica.com/media/media-kit

Community
https://ch.linkedin.com/company/implantica
https://www.twitter.com/implantica

Media Contact:
Implantica AG
Juanita Eberhart, VP Marketing & Advocacy
M: +1 925-381-4581
juanita.eberhart@implantica.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/implantica/r/implantica-deepens-market-penetration-in-italy-with-the-addition-of-the-ninth-refluxstop–center-of-,c4083209

The following files are available for download:

https://mb.cision.com/Main/19732/4083209/3176640.pdf

Implantica deepens market penetration in Italy with the addition of the ninth RefluxStop™ Center of Excellence and several lined up to start near-term

https://news.cision.com/implantica/i/logo-transparent-1-8,c3363581

logo transparent 1 8

https://news.cision.com/implantica/i/reluxstop-product,c3363580

ReluxStop Product

 

View original content:https://www.prnewswire.co.uk/news-releases/implantica-deepens-market-penetration-in-italy-with-the-addition-of-the-ninth-refluxstop-center-of-excellence-and-several-lined-up-to-start-near-term-302333500.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Agri-Food Tech Startups Led by Taiwan’s HAOSHi Attend SusHi Tech Tokyo 2026 to Build Industry and Investment Connections

Published

on

By

TAIPEI and TOKYO, April 28, 2026 /PRNewswire/ — A delegation of three food-tech startups led by Taiwan-based agri-food tech accelerator HAOSHi recently participated in SusHi Tech Tokyo 2026, a global innovation event held in Japan. Through the exhibition and local industry engagement, the initiative aims to help Taiwanese startups establish partnerships with Japanese companies and explore potential investment opportunities.

SusHi Tech Tokyo has emerged as a key innovation platform in Japan, with a focus on urban development and technology applications. As Japan transitions into a super-aged society, demand for functional foods and precision health solutions continues to rise. In response, the Taiwanese delegation brought a focused approach to health and biotech applications, showcasing the R&D capabilities of Taiwan’s food-tech and precision nutrition sectors.

Ahead of the exhibition, HAOSHi worked with Sustainable Food Asia (SFA), a Japan-based organization engaged in sustainable food innovation, to arrange industry exchanges and company visits, giving the startups a more practical understanding of the local market. The trip also facilitated discussions between the Taiwanese teams and Japanese startups including Algalex, Eclipse Foods, and Morus, covering supply chain collaboration and market entry strategies. Through product demonstrations and tastings, the startups established initial business connections with companies in the cosmeceuticals, biotech, food manufacturing, and supply chain sectors.

The two organizations also co-hosted “Sustainable Food Night,” a networking event that drew around 30 representatives from established companies, startups, and investors. Discussions centered on collaboration opportunities in the agri-food tech sector across Taiwan, Japan, and Southeast Asia, with the broader aim of strengthening regional connectivity.

The three participating startups were Space Ark Bio, King Noodles, and Leeuwenhoek Laboratories, which specialize in fermentation applications, functional foods, and precision nutrition, respectively. Amber Lin, CEO of HAOSHi, said that the exhibition and in-market networking helped lay the groundwork for the startups to enter the market and support follow-up business discussions. The initiative also aligns with the goal of Startup Island Taiwan (SIT), which aims to connect Taiwanese startups more closely with the global innovation ecosystem.

 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/agri-food-tech-startups-led-by-taiwans-haoshi-attend-sushi-tech-tokyo-2026-to-build-industry-and-investment-connections-302756448.html

SOURCE HAOSHi Accelerator

Continue Reading

Technology

DB HiTek to Participate in PCIM 2026, Strengthening Its Presence in the European Market

Published

on

By

Europe’s largest power semiconductor exhibition to be held in Nuremberg, Germany, from June 9 to 11Showcasing latest developments in SiC and GaN, highlighting its power semiconductor capabilities

SEOUL, South Korea, April 29, 2026 /PRNewswire/ — DB HiTek, a leading 8-inch pure-play foundry, announced its participation in PCIM (Power Conversion and Intelligent Motion) Europe 2026, the continent’s premier exhibition for power semiconductors. The event will take place in Nuremberg, Germany, from June 9 to 11 (local time), as the company continues expanding its presence in the European market.

Following its successful debut at PCIM in 2025—where the company held face-to-face meetings with dozens of customers to discuss process technologies and collaboration opportunities—DB HiTek is building on that momentum. With over 1,000 booth visitors last year and ongoing business discussions, the company expects these engagements to translate into tangible business results this year through continued partnerships.

At this year’s event, DB HiTek will present progress in its next-generation SiC (Silicon Carbide) and GaN (Gallium Nitride) processes. The company will also highlight its industry-leading BCDMOS (Bipolar-CMOS-DMOS) technology, a core strength of its power management portfolio. A robust schedule of meetings with global clients is already in place, reflecting continued growth in collaboration.

According to market research firm Yole Développement, the global SiC and GaN power semiconductor markets are set for rapid growth. The SiC market is projected to grow from approximately $4.8 billion in 2026 to $10.4 billion by 2030, representing a compound annual growth rate (CAGR) of 21%. Over the same period, the GaN market is expected to expand from $900 million to $2.9 billion, reflecting a CAGR of 33%.

DB HiTek started MPW (Multi-Project Wafer) runs for its SiC and GaN processes in December 2025, producing samples for more than 10 customer products. These were delivered between March and April 2026. Customer evaluations are underway, with feedback to be incorporated into final process verification. Full-scale mass production is scheduled to begin in 2027.

Currently, DB HiTek maintains mass production relationships with approximately 400 customers, primarily focused on its flagship power semiconductor products. The company also works with a broad client base using specialized image sensor technologies, including X-ray, Global Shutter, and SPAD (Single Photon Avalanche Diode). Its application mix is increasingly shifting toward industrial and automotive-grade products, reflecting growing demand from these sectors.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/db-hitek-to-participate-in-pcim-2026-strengthening-its-presence-in-the-european-market-302754538.html

SOURCE DB HiTek

Continue Reading

Technology

LG Display’s 27-inch DFR Gaming OLED panel wins SID’s ‘Display of the Year’

Published

on

By

SEOUL, South Korea, April 28, 2026 /PRNewswire/ — LG Display, the world’s leading innovator of display technologies, announced that its 27-inch 540/720Hz Dynamic Frequency & Resolution (DFR) Gaming OLED panel has been awarded “Display of the Year” by the Society for Information Display (SID), receiving high acclaim for redefining the gaming display paradigm and accelerating market differentiation.

The “Display of the Year” award is SID’s most prestigious distinction, presented to the most groundbreaking display product launched during the previous year that is expected to lead the future of the industry.

This achievement recognizes LG Display’s new user-centered display paradigm. The product’s standout feature is the company’s proprietary DFR technology, which allows users to freely select the mode that suits their preferred gaming style.

High-refresh-rate mode particularly proves its value in game genres where rapid screen transitions are essential and victory is decided in a split second — like first-person shooters or racing games. By supporting an industry-leading refresh rate of 720Hz with HD resolution, this mode eliminates ghosting and motion blur even in the fastest scenes, enabling overwhelming gaming performance.

High-resolution mode provides an optimized visual experience for games based on stunning graphics. It simultaneously delivers QHD resolution and a 540Hz refresh rate. To overcome the conventional limitation where picture quality drops once the refresh rate exceeds 500Hz, LG Display applied a proprietary algorithm, securing the two core elements of a high refresh rate and high picture quality.

As a result, the panel obtained ClearMR 21000 certification, the highest rating from the Video Electronics Standards Association (VESA).

“Our goal is to continue leading the gaming display market by leveraging LG Display’s differentiated OLED technologies and relentless pursuit of innovation,” said Young-seok Choi, Chief Technology Officer of LG Display.

SID is the world’s largest display society with more than 7,000 industry experts, researchers, and professors. It hosts Display Week annually, featuring new technologies, product exhibitions, and academic presentations. SID Display Week 2026 will take place in Los Angeles, California from May 3 to 8.

※ LG Display 27-inch 540/720Hz (DFR) OLED Gaming Monitor Panel Specifications

Category

High-refresh-rate mode

High-resolution mode

Peak Brightness

1,500nits

1,500nits

Refresh Rate / Resolution

720Hz / HD

540Hz / QHD

Response Time

0.02ms

0.02ms

 

About LG Display
LG Display Co., Ltd. [NYSE: LPL, KRX: 034220] is the world’s leading innovator of display technologies, including thin-film transistor liquid crystal and OLED displays. The company manufactures display panels in a broad range of sizes and specifications primarily for use in TVs, notebook computers, desktop monitors, automobiles, and various other applications, including tablets and mobile devices. LG Display currently operates manufacturing facilities in Korea and China, and back-end assembly facilities in Korea, China, and Vietnam. The company has approximately 70,707 employees operating worldwide. For more news and information about LG Display, please visit www.lgdisplay.com.

Media Contact:
Joo Yeon Jennifer Ha, Team Leader, Communication Team
Email: hjy05@lgdisplay.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/lg-displays-27-inch-dfr-gaming-oled-panel-wins-sids-display-of-the-year-302755502.html

SOURCE LG Display

Continue Reading

Trending